Micro-IGES - Microscopic Image Guided Endoluminal Surgery
In plain English
AI plain-English summarySurgeons are testing a new platform that lets them see through tissue in real time while removing early-stage cancers through a flexible tube, without making a single incision. Current endoluminal surgery—where doctors reach tumours through natural openings like the mouth or anus—is unreliable. The instruments are crude, the view is poor, and the tissue moves and deforms. As a result, surgeons often cannot tell whether they have removed the entire tumour, leading to incomplete excision, bleeding, or accidental perforation. This forces many patients to undergo radical surgery instead, which carries significant risks of death and life-altering side effects. The Micro-IGES platform combines probe-based microscopic imaging, integrated sensing, and instruments that account for 3D tissue deformation. It gives surgeons a “see-through” view of excision margins during the procedure. The research team will test the platform first in animal models, then in human studies. If it works, the platform could transform care for patients with early-stage gastrointestinal, respiratory, or nasopharyngeal cancers. It offers the potential for a single procedure that both diagnoses and treats the tumour, reduces surgical trauma, and opens up treatment to elderly patients and those with other health conditions who cannot tolerate major surgery.
View original technical description
View the original record at the funder ↗
Related Research
Grants with similar aims, by meaning.
Original classification
ResearchPlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know